Int J Colorectal Dis (2017) 32:1313–1319 DOI 10.1007/s00384-017-2847-z ORIGINAL ARTICLE Antibiotic treatment for uncomplicated and mild complicated diverticulitis: outpatient treatment for everyone 1 1 1 1 Gaëtan-Romain Joliat & Jonathan Emery & Nicolas Demartines & Martin Hübner & 2 1 Bertrand Yersin & Dieter Hahnloser Accepted: 20 June 2017 /Published online: 29 June 2017 Springer-Verlag GmbH Germany 2017 Abstract rates to the questionnaire were 56% (IT) vs. 62% (OT), Purpose Antibiotic treatment is the treatment of choice for p = 0.18. Failure rates were 32% in IT vs. 10% in OT group, uncomplicated diverticulitis (uD) and can be performed for p < 0.01. Among the uD/mcD patients, admission/CT time mild complicated diverticulitis (mcD). In several cases, out- between midnight and 6 AM, Ambrosetti score of 4, and free patient treatment (OT) can be undertaken. This study assessed air around the colon were risk factors for failure. the 1-month failure rate of OT for uD/mcD compared to inpa- Conclusions Outpatient treatment for uncomplicated/mild tient treatment (IT), and identified predictive factors for treat- complicated diverticulitis is feasible and safe. Prognostic fac- ment failure. tors of failure necessitating closer follow-up were admission/ Methods All consecutive patients (2006–2012) diagnosed CT time, Ambrosetti score
International Journal of Colorectal Disease – Springer Journals
Published: Jun 29, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera